Biotechnology
Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment, Acquires IP From World Leader in Respiratory Disease Medicine
Technology, expertise from UK's Mucokinetica to accelerate repurposing of generic remedy nafamostat for COVID-19 oral, inhalation therapy SAN DIEGO, Aug. 7, 2020 /PRNewswire/ -- A biopharmaceutical company repurposing nafamostat, a generic remedy for pancreatitis and acute kidney injury, is one ...
2020-08-07 01:30
4030
Dietary cholesterol and phytosterols contribute directly to heart disease
Genetic variability in cholesterol and phytosterol absorption affects cardiovascular disease risk REYKJAVIK, Iceland, Aug. 7, 2020 /PRNewswire/ -- Scientists at deCODE genetics , a subsidiary of Amgen, and their collaborators fromthe Icelandic healthcare system, University of Iceland, the Copenha...
2020-08-07 01:21
5728
Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development
Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to announce a new partnership that will offer gl...
2020-08-06 20:10
2895
Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma
SINGAPORE, Aug. 6, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a
clinical-stage cell therapy company developing next-generation cancer
treatments, today announced the publication of results in theJournal of
Clinical Oncology
2020-08-06 19:00
3133
Thailand's Eastern Economic Corridor Promotes Genomics Project as Center of Medical Hub
BANGKOK, Aug. 6, 2020 /PRNewswire/ -- Thailand, already famed for its world class hospitals and success combating coronavirus, aims to enhance its role as a global medical hub by establishing a Thailand Genomics Sequencing Center in the country's high-tech Eastern Economic Corridor (EEC), officia...
2020-08-06 18:47
5842
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
NEW BRUNSWICK, New Jersey, Aug. 5, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses...
2020-08-05 20:30
6942
WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor
SHANGHAI, Aug. 4, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it was awarded as "Most Honored Company" byInstitutional Investor , an international financial publication, based on the strength o...
2020-08-04 17:00
2905
Adagio Medical, Inc., reports pre-clinical effectiveness combining their existing ultra-low temperature cryoablation catheter with Pulsed Field Ablation (PFA) in a single Pulsed Field Cryoablation (PFCA) catheter
LAGUNA HILLS, California, Aug. 4, 2020 /PRNewswire/ -- Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AFib) and ventricular tachycardia (VT), and developer of theintelligent Continuous Lesion Ablation System (iCLAS™), today announced successful pre-clinical re...
2020-08-04 10:16
2948
Macrogen Obtains Europe's CE-IVD Certificate for its COVID-19 Test Kit
SEOUL, South Korea, Aug. 4, 2020 /PRNewswire/ -- The Korean biotech company
Macrogen
2020-08-04 10:00
4698
GranBio and NextChem sign partnership to develop cellulosic ethanol market
SAO PAULO and ROME, Aug. 3, 2020 /PRNewswire/ -- GranBio, a 100% Brazilian industrial biotechnology company, and NextChem, Maire Tecnimont's subsidiary for energy transition announced a strategic partnership to achieve global leadership in the licensing of patented GranBio 2G Ethanol technology t...
2020-08-03 20:54
3601
Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China
SUZHOU, China, Aug. 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...
2020-08-03 08:00
9296
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus
- INO-4800 showed durable antibody and T cell responses in rhesus macaques for 4 months - INO-4800 is the only vaccine to demonstrate long-term protection in non-human primates challenged with SARS-CoV-2 virus 13 weeks from vaccination - Memory T and B cell responses resulted in reduced viral l...
2020-07-30 20:34
6153
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
Study published in Nature shows J&J's investigational SARS-CoV-2 vaccine elicits a strong immune response that protects against subsequent infection First-in-human Phase 1/2a clinical trial now underway in United States and Belgium; Phase 3 clinical trial expected to commence in September NEW BR...
2020-07-30 17:55
10603
Global X China Biotech ETF and Global X China Cloud Computing ETF Named the Most Innovative ETFs in Hong Kong by The Asset
HONG KONG, July 30, 2020 /PRNewswire/ -- Mirae Asset Global Investments (Hong Kong) Limited ("Mirae Asset") is delighted that two of its Hong Kong-listed exchange-traded funds (ETF), theGlobal X China Biotech ETF (2820.HK) and Global X China Cloud Computing ETF (2826.HK), have been recognized as ...
2020-07-30 17:15
4539
Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, trastuzumab biosimilar
SHANGHAI, July 30, 2020 /PRNewswire/ -- The European Commission (EC) has approved Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord)'s Zercepac®, a biosimilar trastuzumab, for the treatment of certain patients with HER2-positive early breast cancer, HER2-positive meta...
2020-07-30 08:00
5647
Global Cord Blood Corporation Files Its Annual Report on Form 20-F
HONG KONG, July 30, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...
2020-07-30 04:16
18204
SEKISUI Diagnostics Invests £14.4 Million in cGMP Biopharma CDMO Capacity
BURLINGTON, Mass., July 29, 2020 /PRNewswire/ -- Sekisui announces the decision to invest £14.4 Million in its biopharma CDMO business aimed atcGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022. This investment follows the investme...
2020-07-29 21:00
3682
INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory Papillomatosis (RRP)
PLYMOUTH MEETING, Pennsylvania, July 29, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO) today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for INO-3107, its DNA medicine being evaluated in a Phase 1/2 trial for treatment of recurrent respiratory papillomat...
2020-07-29 19:30
4761
BIO Asia-Taiwan 2020 Concludes Successfully
TAIPEI, July 29, 2020 /PRNewswire/ -- BIO Asia-Taiwan 2020 International Conference and Exhibition, the world's first combined onsite plus online biotechnology conference, closed onJuly 26. Held in Taipei, from July 22 to 26, the event attracted over 5,000 viewers to its online conference, of whi...
2020-07-29 17:35
3001
Celltrion Selects Movilitas for Serialization and Traceability Implementations to Ensure Supply Chain Integrity and Compliance
Project delivers a combined solution for end-to-end visibility in EU, Korea and U.S. markets COLUMBIA, Maryland, July 29, 2020 /PRNewswire/ -- Movilitas, a technology leader delivering the next generation of solutions and consulting services across multiple industries to advance smart supply cha...
2020-07-29 09:38
2788
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 309 media titles]
2025-01-13 09:05
ASTON MARTIN ARAMCO FORMULA ONE® TEAM ANNOUNCE PEPPERSTONE AS OFFICAL TRADING PARTNER
[Picked up by 308 media titles]
2025-01-07 09:00
iWOW Unveils Age-Tech Innovations at CES 2025, Expanding Portfolio of IoT Solutions for Ageing-In-Place
[Picked up by 294 media titles]
2025-01-07 21:18URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 287 media titles]
2025-01-13 10:44
Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 283 media titles]
2025-01-10 16:04Most Read
Hyundai Motor Group Partners with NVIDIA to Accelerate Development of AI Solutions for Future Mobility
2025-01-10 01:00
19268
AIMA Unveils Game-Changing 2025 eBike Lineup at CES: Better Performance, More Freedom
2025-01-09 02:34
5909
ASTON MARTIN ARAMCO FORMULA ONE® TEAM ANNOUNCE PEPPERSTONE AS OFFICAL TRADING PARTNER
2025-01-07 09:00
5279
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
4661
